Hepatic decompensation in patients with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) triple infection versus HIV/HCV coinfection and the effect of Anti-HBV Nucleos(t)ide therapy

Clinical Infectious Diseases

Volumn 59, Issue 7, 2014, Pages 1027-1031

  Re, Vincent Lo ^a,b   Wang, Li ^c   Devine, Scott ^d   Baser, Onur ^c,e   Olufade, Temitope ^d  

^a Penn Center for AIDS Research   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STATINMED RESEARCH   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e MEF UNIVERSITY   (Turkey)

Author keywords

End stage liver disease; Hepatic decompensation; Hepatitis B; Hepatitis C; HIV

Indexed keywords

ADEFOVIR; ANTIRETROVIRUS AGENT; EMTRICITABINE; ENTECAVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; TELBIVUDINE; TENOFOVIR; ANTIVIRUS AGENT; NUCLEOTIDE;

ADULT; ARTICLE; COHORT ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT INDICATION; COINFECTION; COMPLICATION; HIV INFECTIONS; INCIDENCE; LIVER FAILURE;

ANTIVIRAL AGENTS; COHORT STUDIES; COINFECTION; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; LIVER FAILURE; MALE; MIDDLE AGED; NUCLEOTIDES; RETROSPECTIVE STUDIES;

EID: 84929942627     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu476     Document Type: Article

References (25)

1. Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004; 18:2039-45.
2. Arribas JR, Gonzalez-Garcia JJ, Lorenzo A, et al. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS 2005; 19:1361-5.
3. Sollima S, Caramma I, Menzaghi B, et al. Chronic coinfection with hepatitis B and hepatitis C viruses in an Italian population of HIV-infected patients. J Acquir Immune Defic Syndr 2007; 44:606-7.
4. Rong-Rong Y, Xi-En G Shi-Cheng G, Yong-Xi Z. Interaction of hepatitis B and C viruses in patients infected with HIV. J Acquir Immune Defic Syndr 2008; 48:505-6.
5. Kim JH, Psevdos G Suh J, Sharp VL. Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States. World J Gastroenterol 2008; 14:6689-93.
6. Hui CK, Leung N, Yuen ST, et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology 2007; 46:395-401.
7. Sagnelli E, Coppola N, Scolastico C, et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000; 32:1106-10.
8. Morsica G, Bagaglio S, Cicconi P, et al. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. J Acquir Immune Defic Syndr 2009; 51:574-81.
9. Soriano V, Barreiro P, Martin-Carbonero L, et al. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis. J Infect Dis 2007; 195:1181-3.
10. Boyd A, Lacombe K, Miailhes P, et al. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. J Viral Hepat 2010; 17:65-76.
11. Kashner TM. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care 1998; 36:1324-36.
12. Justice AC, Erdos J, Brandt C, Conigliaro J, Tierney W, Bryant K. The Veterans Affairs Healthcare System: A unique laboratory for observational and interventional research. Med Care 2006; 44(8 suppl 2):S7-12.
13. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012; 308:387-402.
14. Fultz SL, Skanderson M, Mole LA, et al. Development and verification of a "virtual" cohort using the national VA health information system. Med Care 2006; 44(8 suppl 2):S25-30.
15. Byrne DD, Newcomb CW, Carbonari DM, et al. Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007. Ann Epidemiol 2014; 2014; 24:418-23.
16. Berenguer J, Alvarez-Pellicer J, Martin PM, et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009; 50:407-13.
17. Limketkai BN, Mehta SH, Sutcliffe CG, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV JAMA 2012; 308:370-8.
18. Lo Re V III, Lim JK, Goetz MB, et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharma-coepidemiol Drug Saf 2011; 20:689-99.
19. Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection. Hepatology 2004; 40:115-9.
20. Justice AC, McGinnis KA, Atkinson JH, et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care. Veterans Aging Cohort Five-Site Study. AIDS 2004; 18(suppl 1):S49-59.
21. Kazis LE, Miller DR, Clark J, et al. Health-related quality of life in patients served by the Department of Veterans Affairs: results from the Veterans Health Study. Arch Intern Med 1998; 158:626-32.
22. Collett D. Modeling survival data in medical research. 2nd ed. New York. NY: Chapman and Hall, 2003.
23. Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time-to-event data. New York, NY: John Wiley & Sons, 1999.
24. Martin-Carbonero L, Teixeira T, Poveda E, et al. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS 2011; 25:73-9.
25. Lo Re V III, Kallan MJ, Tate JP, et al. Hepatic decompensation in anti-retroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med 2014; 160:369-79.